Back to Awarded Treatment Trials
Awarded Trial: 17T-005
Grant ID
17T-005
Illness
Bipolar depression
Primary Drug/Intervention
probiotic microorganisms (Lactobacillus GG, Bifidobacteria lactis strain Bb12)
Primary Dosage
10^8 colony forming units
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Enrolling
Investigator
Sherwood Brown, M.D., Ph.D.
Sample Size
66
Duration of Study Period for Each Subject
24 weeks
Outcome Measurements
Primary outcome: Relapse, defined as rehspitalization (e.g., admission to an inpatient unit) for psychiatric symptoms following a previous hospital discharge by at least 2 weeks. Secondary outcomes: Occurrence of new mood episodes, severity of psychiatric symptoms, changes in cognitive test scores over the course of the study, changes in the levels of inflammatory markers, changes in gut microbiota.
Results
N/A
Publication
N/A
Link
N/A
PI Name
Sherwood Brown
Degree
M.D., Ph.D.
Center
University of Texas Southwestern Medical Center
Institution
N/A
Address
5323 Harry Hines Blvd, MC 8849
City or Town
Dallas
State or Province
TX
Zip or Postal Code
75390
Country
USA
Email Address
Sherwood.brown@utsouthwestern.edu